Your Wednesday Daily News Digest

by Mark Zalewski

February 15, 2017

In today’s CyclingTips Daily News Digest: Kristoff wins Tour of Oman opener; US judge denies Armstrong request, federal whistleblower case headed to jury trial; Tramadol: Why Some Athletes and Experts Want It Banned; Boonen crashes in Oman, okay to start second stage; Chris Hoy: Cycling needs a shake up; Three Days De Panne-Koksijde signs 10 year agreement with events company Golazo; Gent-Wevelgem announces final teams; Merckx: Tour of Qatar unlikely for 2018; Hennie Kuiper searching for infamous photographer; Wout van Aert tops prize money list; Crash in amateur race after elbows thrown; Behind the scenes making a carbon frame; Film: To The Night.

Tramadol: Why Some Athletes and Experts Want It Banned

by CyclingTips

The powerful painkiller tramadol has been in the news with increasing frequency as riders open up about its use in the peloton and the MPCC, UCI and World Anti-Doping Agency (WADA) in dispute over whether to ban it, with WADA deciding not to for this year. The US Anti-Doping Agency (USADA) disagrees with WADA and published this feature to urge WADA to add tramadol to the prohibited list. Here is an excerpt:

The narcotic painkiller tramadol is a still-legal substance in sport that is both powerful and dangerous. USADA, alongside numerous other organizations in the world of sport, believe that the time is now for WADA to finally move the drug from its Monitoring Program (where it has been since 2012) to the Prohibited List, alongside 12 other narcotics that are already banned in-competition.

While USADA and other consulted stakeholders provided substantial evidence about the health risks and abuse of tramadol in sport after WADA requested comment on its inclusion in 2015, WADA has not yet added the drug, which is being abused in at least one sport. According to the WADA Monitoring Program, 71 to 82 percent of the tramadol use between 2012 and 2015 in globally monitored sports occurred in cycling.

Without doubt, tramadol raises legitimate questions about how it should be regulated in sport, as it has both clinical utility and potential for abuse. The debate becomes particularly complex when a drug is associated so closely with a single sport.

However, the enormity of the drug’s threat becomes more apparent when some athletes talk about their experiences with the powerful painkiller.

Click through to read more at USADA.